Showing results (371-380 of 2,886) with videos related to
Sort By:
Pageof 289
Journal of Diabetes|December 14, 2023
Clinical outcomes of obese and nonobese patients with atrial fibrillation according to associated metabolic abnormalities: A report from the COOL-AF registryRungroj Krittayaphong, Thanita Boonyapiphat, Arjbordin Winijkul, et al.Expert Opinion on Drug Safety|October 20, 2023
Balancing the risk of stroke and bleeding in atrial fibrillation patients with a history of fallsNang Khaing Zar Latt, Peter Calvert, Gregory Y H LipClinical Cardiology|August 30, 2014
Stroke and bleeding risk in atrial fibrillation: navigating the alphabet soup of risk-score acronyms (CHADS2 , CHA2 DS2 -VASc, R2 CHADS2 , HAS-BLED, ATRIA, and more)Mikhail S Dzeshka, Deirdre A Lane, Gregory Y H LipPharmacological Research|April 27, 2018
Prognostic and therapeutic implications of vascular disease in patients with atrial fibrillationFarhan Shahid, Daniele Pastori, Francesco Violi, et al.Current Heart Failure Reports|August 1, 2018
Heart Failure and StrokeKatja Schumacher, Jelena Kornej, Eduard Shantsila, et al.The Lancet Regional Health. Europe|February 16, 2024
Atrial fibrillation: stroke preventionTze-Fan Chao, Tatjana S Potpara, Gregory Y H LipEuropean Journal of Internal Medicine|July 24, 2023
Predicting acute and long-term mortality in a cohort of pulmonary embolism patients using machine learningWahbi K El-Bouri, Alexander Sanders, Gregory Y H Lip, et al.Annals of Medicine|January 20, 2011
The CD40-CD40L system in cardiovascular diseaseBurak Pamukcu, Gregory Y H Lip, Viktor Snezhitskiy, et al.Nature Reviews. Nephrology|March 27, 2018
Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunctionTatjana S Potpara, Charles J Ferro, Gregory Y H LipThe Journal of Clinical Endocrinology and Metabolism|November 9, 2004
Plasma von Willebrand factor and the development of the metabolic syndrome in patients with hypertensionHoong Sern Lim, Gregory Y H Lip, Andrew D BlannPageof 289